arrow
D

Diego Clemente

instituto de salud carlos iii
H指数:29
被引数:2,331

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

“Recommendations for clinical study protocols for immune and inflammatory profiling in Parkinson’s disease”

“关于帕金森病免疫和炎症谱临床研究方案的推荐”

2025-10-200
OAAI
Relevance of a peripheral site of action outside the brain-blood barrier for the beneficial effects of CB2 receptor activation in experimental ALS in male mice

在实验性肌萎缩侧索硬化症(ALS)雄性小鼠中,CB2受体激活的有益效果与血脑屏障外周作用位点的相关性

2025-10-120
OAAI
Circulating myeloid-derived suppressor cell load and disease severity are associated to an enhanced oligodendroglial production in a murine model of sclerosis

循环髓源抑制性细胞负荷与疾病严重程度在一种硬化症小鼠模型中与增强的少突胶质细胞生成相关联

2025-06-010
OAAI
Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis
2023-05-275
OA
Myeloid-derived suppressor cells support remyelination in a murine model of multiple sclerosis by promoting oligodendrocyte precursor cell survival, proliferation, and differentiation

髓源性抑制细胞通过促进少突胶质前体细胞存活,增殖和分化来支持多发性硬化小鼠模型中的髓鞘再生

GLIA
IF5.1
2020-11-2026
OAAI
The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis

在多发性硬化症的小鼠模型中,脾脏中髓源性抑制细胞的比例与临床过程的严重程度和组织损伤程度有关。

2020-07-0131
OAAI
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients

NLRP3炎性小体作为原发性进行性多发性硬化患者的预后因素和治疗靶点

BRAIN
IF11.7
2020-04-1397
OAAI
The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-β treatment in a murine model of multiple sclerosis

在多发性硬化症的小鼠模型中,干扰素-β 治疗后,髓源性抑制细胞的存在和抑制活性得到增强

2019-07-0132
OAAI